Alzheimer's Archives · BioBuzz

Loading …

Why The Next Biotech Boom Could be Sparked by New Therapies for Neurological Disorders

<img width="300" height="300" alt="" data-srcset="https://biobuzz.io/wp-content/uploads/2019/12/Copy-of-Featured-Images--300x300.jpg 300w, https://biobuzz.io/wp-content/uploads/2019/12/Copy-of-Featured-Images--100x100.jpg 100w, https://biobuzz.io/wp-content/uploads/2019/12/Copy-of-Featured-Images--150x150.jpg 150w, https://biobuzz.io/wp-content/uploads/2019/12/Copy-of-Featured-Images--75x75.jpg 75w" data-src="https://biobuzz.io/wp-content/uploads/2019/12/Copy-of-Featured-Images--300x300.jpg" data-sizes="(max-width: 300px) 100vw, 300px" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image lazyload lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img width="300" height="300" src="https://biobuzz.io/wp-content/uploads/2019/12/Copy-of-Featured-Images--300x300.jpg" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image lazyload" alt="" srcset="https://biobuzz.io/wp-content/uploads/2019/12/Copy-of-Featured-Images--300x300.jpg 300w, https://biobuzz.io/wp-content/uploads/2019/12/Copy-of-Featured-Images--100x100.jpg 100w, https://biobuzz.io/wp-content/uploads/2019/12/Copy-of-Featured-Images--150x150.jpg 150w, https://biobuzz.io/wp-content/uploads/2019/12/Copy-of-Featured-Images--75x75.jpg 75w" sizes="(max-width: 300px) 100vw, 300px" />

Published on : December 3, 2019December 7, 2019 Published by : Sharlene Brown, PhD

Why The Next Biotech Boom Could be Sparked by New Therapies for Neurological Disorders Several Maryland Biotech Firms Are Blazing New Trails in Gene Therapy, Drugs and Diagnostics for Neurological [….]

Germantown, MD-based Neuraly & Theraly Fibrosis Advance Clinical Parkinson’s and Alzheimer’s Candidates with $137.1M in Series B Financing Raised by Parent Company D&D Pharmatech

<img width="300" height="300" alt="" data-srcset="https://biobuzz.io/wp-content/uploads/2019/08/cropped-DD_logo-300x300.jpg 300w, https://biobuzz.io/wp-content/uploads/2019/08/cropped-DD_logo-100x100.jpg 100w, https://biobuzz.io/wp-content/uploads/2019/08/cropped-DD_logo-150x150.jpg 150w, https://biobuzz.io/wp-content/uploads/2019/08/cropped-DD_logo-75x75.jpg 75w" data-src="https://biobuzz.io/wp-content/uploads/2019/08/cropped-DD_logo-300x300.jpg" data-sizes="(max-width: 300px) 100vw, 300px" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image lazyload lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img width="300" height="300" src="https://biobuzz.io/wp-content/uploads/2019/08/cropped-DD_logo-300x300.jpg" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image lazyload" alt="" srcset="https://biobuzz.io/wp-content/uploads/2019/08/cropped-DD_logo-300x300.jpg 300w, https://biobuzz.io/wp-content/uploads/2019/08/cropped-DD_logo-100x100.jpg 100w, https://biobuzz.io/wp-content/uploads/2019/08/cropped-DD_logo-150x150.jpg 150w, https://biobuzz.io/wp-content/uploads/2019/08/cropped-DD_logo-75x75.jpg 75w" sizes="(max-width: 300px) 100vw, 300px" />

Published on : August 14, 2019September 26, 2020 Published by : Chris Frew

Neuraly Theraly Fibrosis raise $137.1M in Series B from Korean Parent Company DD Pharmatech

3 Promising Maryland Biotechs that are Targeting Neurological Disorders

<img width="300" height="300" alt="" data-srcset="https://biobuzz.io/wp-content/uploads/2019/02/Brainscope-300x300.jpg 300w, https://biobuzz.io/wp-content/uploads/2019/02/Brainscope-100x100.jpg 100w, https://biobuzz.io/wp-content/uploads/2019/02/Brainscope-150x150.jpg 150w, https://biobuzz.io/wp-content/uploads/2019/02/Brainscope-75x75.jpg 75w" data-src="https://biobuzz.io/wp-content/uploads/2019/02/Brainscope-300x300.jpg" data-sizes="(max-width: 300px) 100vw, 300px" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image lazyload lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img width="300" height="300" src="https://biobuzz.io/wp-content/uploads/2019/02/Brainscope-300x300.jpg" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image lazyload" alt="" srcset="https://biobuzz.io/wp-content/uploads/2019/02/Brainscope-300x300.jpg 300w, https://biobuzz.io/wp-content/uploads/2019/02/Brainscope-100x100.jpg 100w, https://biobuzz.io/wp-content/uploads/2019/02/Brainscope-150x150.jpg 150w, https://biobuzz.io/wp-content/uploads/2019/02/Brainscope-75x75.jpg 75w" sizes="(max-width: 300px) 100vw, 300px" />

Published on : February 12, 2019April 2, 2019 Published by : Rajamani Selvam

3 Promising Maryland Biotechs that are Targeting Neurological Disorders BrainScope, AgeneBio and Neuraly February 13, 2019 Neurological disorders are diseases of the central nervous system such as Alzheimer’s and Parkinson’s. [….]